Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
![]() |
fig.5.f
Agüero TH et al. (2012) |
Xla Wt + ihhdel_591-819
NF16 (in situ hybridization) |
|
|||||
![]() |
fig.4.b
Agüero TH et al. (2012) |
Xla Wt + dnihhdel_84-582
NF16 (in situ hybridization) |
|
|||||
![]() |
fig.2.g, h
Bentaya S et al. (2012) |
Xla Wt + rbm38
NF18 (in situ hybridization) |
|
|||||
![]() |
fig.S2.b
Bentaya S et al. (2012) |
Xla Wt + rbm38 MO
NF18 (morphology) |
|
|||||
![]() |
Fig 4B
Vandenberg LN et al. (2011) |
Xla Wt + atp6v0cdel
NF14 (in situ hybridization) |
|
|||||
![]() |
Fig 4D
Vandenberg LN et al. (2011) |
Xla Wt + atp6v0cdel
NF20 (in situ hybridization) |
|
|||||
![]() |
Fig 4 K
Vandenberg LN et al. (2011) |
Xla Wt + atp6v0cdel
NF25 (in situ hybridization) |
|
|||||
![]() |
Fig 5 A upper panel
Vandenberg LN et al. (2011) |
Xla Wt + Concanamycin
NF13-15 (in situ hybridization) |
|
|||||
![]() |
Fig 5 A lower panel
Vandenberg LN et al. (2011) |
Xla Wt + Concanamycin
NF14-16 (in situ hybridization) |
|
|||||
![]() |
fig.6.a
Neuner R et al. (2009) |
Xla Wt + adam19 MO
NF15 (in situ hybridization) |
|